Washington takes a stand on biotechnology

Gavaghan, H.
March 1992
New Scientist;3/7/92, Vol. 133 Issue 1811, p10
Reports on the long awaited guidelines from the United States for agencies that regulate the release of biotechnology products into the environment. These stress that all products must be treated in the same way. Guidelines embody findings of the National Research Council; Emphasis on risk rather than the method of production; These encourage the slide of European companies to the US.


Related Articles

  • New biotechnology: The promise withers. Miller, Henry // American Enterprise;Sep/Oct94, Vol. 5 Issue 5, p54 

    Discusses the regulatory problems regarding biotechnology. Medical breakthroughs due to biotechnology; Debate over the regulation of biotechnology; Scientific community's assumptions on biotechnology; Regulatory agencies' failure to heed the scientific community's assumptions; Need for...

  • Biotech for consumers.  // Consumer Comments;May/Jun92, Vol. 16 Issue 3, p4 

    Talks about the Food and Drug Administration's (FDA) policy statement on the use of biotechnology in food production which was issued on May 26, 1992. Comments from Dr. Louis Sullivan, Secretary of Health and Human Services; The FDA's policy will allow companies to produce foods using such...

  • FDA gives biotechnology a green light.  // Nation's Health;Jul92, Vol. 22 Issue 6, p12 

    Claims biotechnology firms received a big boost in May when the Bush Administration released guidelines to regulate genetically engineered foods just like traditionally produced foods. Comments from Food and Drug Administration Commissioner David Kessler; Policy developed to be used as a `road...

  • Biotech firms worry cloning will spawn regulations.  // Indianapolis Business Journal;04/14/97, Vol. 18 Issue 4, p33 

    Reports on the concerns of biotechnology companies on the possible increase in regulations resulting from cloning technologies in the United States. Regulation of genetic engineering; Impact of increased regulations on the development of drugs and proteins for fighting and diagnosing diseases.

  • Up to their necks in it. Coghlan, Andy // New Scientist;08/01/98, Vol. 159 Issue 2145, p5 

    Focuses on the legal technicalities of agricultural biotechnology in England. The Ministry of Agriculture, Fisheries and Food's (MAFF) regulations and rules for approving genetically engineered crops; The court case of organic farmer Guy Watson; Tests that bioengineered plants must pass before...

  • Biotech food policy announced.  // FDA Consumer;Sep92, Vol. 26 Issue 7, p5 

    Reports that a policy statement explaining how the Food and Drug Administration will regulate new varieties of whole foods developed through biotechnology was announced last May by HHS Secretary Louis W. Sullivan, M.D. Scientific bases for evaluating and ensuring safety of new varieties of...

  • Biotech directive fails.  // Chemical Week;3/8/1995, Vol. 156 Issue 9, p6 

    Reports on the rejection of the biotechnology directive by the European Parliament. Impact on the pharmaceutical and pesticide industry; Concerns about the genetic treatment of human fetuses.

  • Antipodes clamp down on genetically engineered food. Silva, Wilson da // New Scientist;04/05/97, Vol. 154 Issue 2076, p5 

    Reports on the regulations to be imposed by Australia and New Zealand governing the sale of food made from genetically modified plants or animals. Preparation of the regulations by the Australia and New Zealand Food Authority; Data required on the sale of bioengineered food.

  • UK report criticizes EC directives.  // Nature;10/21/1993, Vol. 365 Issue 6448, p684 

    Reports on Britain's biotechnology industry's efforts to persuade the House of Lords to back its claims that excessive regulation is reducing its ability to compete effectively with companies in both the United States and Japan. Directives issued by the European Commission; Assessing safety...

  • European debate on biotech highlights policy differences. Abbott, Alison // Nature;1/18/1996, Vol. 379 Issue 6562, p197 

    Reports on the trialogue held between the European Commission, the European Parliament and the Council of Ministers to discuss the Parliament's rejection of a draft directive from the Commission on the protection of biotechnological inventions. Revised version of the directive to be published in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics